Yang et al. found 38% of bladder cancer patients have a PPARγ gene amplification, which indicates the unbalance between TR4 and PPARγ plays an important role in both PCa and bladder cancer (21). The gene discussed is NR2C2; the disease is urinary bladder carcinoma.